| Date of Web Publication | 23-Feb-2015 |
Correspondence Address:
Source of Support: None, Conflict of Interest: None
Read associated Original Article: Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers with this article
DOI: 10.4103/1477-3163.151965
How to cite this article:
Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction. J Carcinog 2015;14:2
How to cite this URL:
Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction. J Carcinog [serial online] 2015 [cited 2021 Oct 13];14:2. Available from: https://carcinogenesis.com/text.asp?2015/14/1/2/151965
The article, “Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers” published on page 1-10, Vol 10 of Jan 2011 issue of Journal of Carcinogenesis[1], is being retracted at the request of the University of Maryland, Baltimore. It has been determined that in figures 4 and 5, the western blot bands have been manipulated. Bands have been found to be identical, although claimed to be from different sources and labeled differently. Consequently, the Vice President of Academic Affairs and the Assistant Vice President, Research Integrity have requested the retraction of the article.
Roger J. Ward, EdD, JD, MPA
Chief Accountability Officer
Vice President of Academic Affairs
Vice Dean, Graduate School
University of Maryland, Baltimore
Louise Ramm, PhD
Assistant Vice President, Research Integrity
University of Maryland, Baltimore
References
| 1. |
Almubarak H, Jones A, Chaisuparat R, Zhang M, Meiller TF, Scheper MA. Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers. J Carcinog 2011; 10:2.
 [PUBMED] |